ArticleMicroorganisms2026
Decoupling of Respiratory Virus Positivity and Host Inflammatory Response: A 16-Year Longitudinal Study.
Article in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Given limited evidence on temporal changes in pathogen detection patterns and hospital-based inflammatory burden across the pandemic transition, this study examined their long-term relationship using respiratory multiplex PCR positivity and concurrent C-reactive protein (CRP) levels. We analyzed 19,002 episodes linking respiratory multiplex PCR (mPCR) results and concurrent CRP from October 2008 to December 2024. Pre-pandemic, pandemic, and post-pandemic changes in monthly testing volume, positivity rate, median CRP, high and extreme inflammation by mPCR status, and the correlation between positivity rate and median CRP were assessed. mPCR positivity decreased from 60.62% (pre-pandemic) to 22.45% (pandemic) and remained low at 25.95% thereafter, whereas the median CRP increased from 0.94 to 3.35 and 5.97 mg/dL, respectively. After January 2020, testing volume and positivity rate decreased, whereas the median CRP increased. High inflammation increased from 13.78% to 27.93% and 38.98% in mPCR-negative episodes, and from 4.61% to 7.20% and 27.66% in mPCR-positive episodes, remaining consistently lower in the latter. Monthly positivity rate was strongly negatively correlated with median CRP. Overall, respiratory virus positivity declined, whereas CRP-based inflammatory burden increased, indicating divergent temporal trends across the pandemic transition. These findings should be interpreted descriptively, not causally, as reflecting divergent temporal trajectories of pathogen detection and inflammatory burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.